CUSIP: 14070B101
Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
897,390
-
Share change
-
-50,051
-
Total reported value
-
$3,013,000
-
Price per share
-
$3.38
-
Number of holders
-
21
-
Value change
-
-$99,604
-
Number of buys
-
10
-
Number of sells
-
6
Quarterly Holders Quick Answers
What is CUSIP 14070B101?
CUSIP 14070B101 identifies CAPR - CAPRICOR THERAPEUTICS INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q2 2017
-
Previous quarter:
Q4 2016
Recent filing periods for CUSIP 14070B101:
Institutional Holders of CAPRICOR THERAPEUTICS INC - COM (CAPR) as of Q1 2017
As of 31 Mar 2017,
CAPRICOR THERAPEUTICS INC - COM (CAPR) was held by
21 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
897,390 shares.
The largest 10 holders included
SABBY MANAGEMENT, LLC, LLBH Private Wealth Management, LLC, VANGUARD GROUP INC, JACOBS LEVY EQUITY MANAGEMENT, INC, Granite Point Capital Management, L.P., GOLDMAN SACHS GROUP INC, Apriem Advisors, Frontier Wealth Management LLC, GEODE CAPITAL MANAGEMENT, LLC, and KCG HOLDINGS, INC..
This page lists
21
institutional shareholders reporting positions in this security
for the Q1 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.